Market Analysis
The Tumor Infiltrating Lymphocyte (TIL) Market was valued at US$ 92.5 million in 2024 and is projected to reach US$ 853.5 million by 2032.
Exhibiting a Compound Annual Growth Rate (CAGR) of 30.3% during the forecast period (2025-2032).
Market Segmentation
By Application:
Cervical Cancer
Ovarian Cancer
KidneyCancer
Gastrointestinal Cancer
Head and NeckCancers
By Type:
T-cells
B-cells
Natural Killer Cells
